Applications are invited for a Medical Statistician, to join the Primary Care Clinical Trials Unit (PC-CTU) trial statistics team.
The successful applicant will be expected to contribute to all statistical aspects of clinical trial activities within the PC-CTU and outside the PC-CTU.
This is a full-time position for two years in the first instance.
You will hold a Postgraduate degree in statistics supported by a publication record and experience in working on Clinical Trials as a Medical Statistician.
You will be based in the Gibson Building, Nuffield Department of Primary Care Health Sciences, Radcliffe Primary Care Building, Woodstock Road, Oxford, OX2 6GG as your normal place of work but there may be the opportunity for occasional remote working which you need to agree a pattern of regular remote working with your line manager.
For further information or discuss the post please contact Dr. Milensu Shanyinde milensu.shanyinde@phc.ox.ac.uk
Underfilling the Post: Whilst the role is a grade 7 (£38,674 - £46,913 p.a.) position, we would be willing to consider candidates with potential but less experience who are seeking a development opportunity, for which an initial appointment would be at grade 6 (£34,982 - £40,855 p.a.) with the responsibilities adjusted accordingly. This would be discussed with applicants at the interview or appointment, where appropriate.
“Committed to equality and valuing diversity”
You will be required to upload a CV and Supporting Statement as part of your online application. The Supporting Statement should include a cover letter and should also clearly describe how you meet each of the selection criteria listed in the job description. Click here for information and advice on writing an effective Supporting Statement. Please do not attach any manuscripts, papers, transcripts, mark sheets or certificates as these will not be considered as part of your application.
The closing date for applications is 12:00 noon on Wednesday 13 August 2025.
Interviews are expected to be held on Wednesday 17 September 2025.